Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Oclacitinib maleate (PF-03394197 maleate) is a novel inhibitor of JAK family members with IC50 ranging from 10 to 99 nM and JAK1-dependent cytokines with IC50 ranging from 36 to 249 nM, which did not inhibit a panel of 38 non-JAK kinases.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 33.00 | |
2 mg | In stock | $ 46.00 | |
5 mg | In stock | $ 72.00 | |
10 mg | In stock | $ 101.00 | |
25 mg | In stock | $ 178.00 | |
50 mg | In stock | $ 286.00 | |
100 mg | In stock | $ 480.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 78.00 |
Description | Oclacitinib maleate (PF-03394197 maleate) is a novel inhibitor of JAK family members with IC50 ranging from 10 to 99 nM and JAK1-dependent cytokines with IC50 ranging from 36 to 249 nM, which did not inhibit a panel of 38 non-JAK kinases. |
Targets&IC50 | JAK1-dependent:36 to 249 nM, JAK:10 to 99 nM |
In vitro | PF-03394197 inhibits JAK family members by 50% at concentrations ranging from 10 to 99 nM and does not inhibit a panel of 38 non-JAK kinases. PF-03394197 is most potent at inhibiting JAK1. PF-03394197 also inhibits the function of JAK1-dependent cytokines involved in allergy and inflammation as well as pruritus. PF-03394197 has minimal effects on cytokines which does not activate the JAK1 enzyme in cells[1]. |
In vivo | PF-03394197 administered orally at a dose of 0.4–0.6 mg/kg twice daily is safe and efficacious in controlling the pruritus associated with allergic dermatitis. PF-03394197 provides itch relief within 24 h that persistes through the treatment period, with over 70% of the treated dogs achieving a >50% reduction in pruritus by day 7[2]. |
Synonyms | PF-03394197 maleate, PF-03394197 |
Molecular Weight | 453.51 |
Formula | C15H23N5O2S·C4H4O4 |
CAS No. | 1640292-55-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 15 mg/mL (33.1 mM)
Ethanol: 83 mg/mL (183 mM)
DMSO: 83 mg/mL (183 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Oclacitinib maleate 1640292-55-2 Angiogenesis Chromatin/Epigenetic JAK/STAT signaling Stem Cells Tyrosine Kinase/Adaptors Tyrosine Kinases JAK Oclacitinib PF 03394197 PF-03394197 maleate PF-03394197 Maleate inhibit PF03394197 Maleate PF03394197 Oclacitinib Maleate Inhibitor PF 03394197 Maleate PF-03394197 Janus kinase inhibitor